VISTA expression in this setting has been described in multiple malignancies, including mesothelioma, gastric, HNSCC, renal cell and colorectal cancers, with expression most commonly observed in the TME on myeloid cells (20, 40, 48, 51, 57). Here, VSIR is linked to head and neck squamous cell carcinoma.